ストックスクリーナーアプリを入手
9.17
0.11%
0.010
プレマーケット:
9.17
前日終値:
$9.16
開ける：
$9.21
24時間の取引高:
19,070
Relative Volume:
0.20
時価総額：
$92.16M
収益：
$75.67M
当期純損益:
$-31.15M
株価収益率:
-33.02
EPS:
-0.2777
ネットキャッシュフロー:
$-39.79M
1週間 パフォーマンス:
+1.33%
1か月 パフォーマンス:
+55.95%
6か月 パフォーマンス:
-18.49%
1年 パフォーマンス:
-40.07%
1日の値動き範囲:
$9.15
$9.24
1週間の範囲:
$9.00
$9.28
52週間の値動き範囲:
$4.815
$20.02
Optinose Inc Stock (OPTN) Company Profile
OPTN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OPTN
Optinose Inc
|
9.17 | 92.16M | 75.67M | -31.15M | -39.79M | -0.2777 |
|
ZTS
Zoetis Inc
|
148.67 | 67.28B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.22 | 45.62B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.71 | 45.01B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.65 | 15.60B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
284.73 | 12.77B | 2.76B | 1.11B | 898.10M | 22.77 |
Optinose Inc Stock (OPTN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-20 | ダウングレード | Lake Street | Buy → Hold |
| 2025-01-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2024-03-11 | 開始されました | H.C. Wainwright | Buy |
| 2023-08-21 | 開始されました | Lake Street | Buy |
| 2022-10-21 | 再開されました | Jefferies | Buy |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2019-12-18 | 開始されました | Cowen | Outperform |
| 2018-08-08 | 開始されました | Cantor Fitzgerald | Overweight |
すべてを表示
Optinose Inc (OPTN) 最新ニュース
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: The AZEK Company Inc. (NYSEAZEK), Mesa Air Group, Inc. (NasdaqMESA), Mr. Cooper Group Inc. (Nasdaq – COOP), Optinose, Inc. (NasdaqOPTN) - Morningstar
After Fielding Multiple Offers, Yardley-Based Optinose Secures Potential $330M Deal With Paratek - BUCKSCO.Today
How a Bucks County firm's multiyear pursuit of a partner led to a potential $330M deal - The Business Journals
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COOP, MESA on Behalf of Shareholders - The Malaysian Reserve
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
When (OPTN) Moves Investors should Listen - news.stocktradersdaily.com
STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The MergerOPTN, SLRN, AKYA, SHYF - Lelezard
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN - Bluefield Daily Telegraph
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The Merger – OPTN, SLRN, AKYA, SHYF - GlobeNewswire Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HMST, COOP, OPTN, RDFN on Behalf of Shareholders - The Malaysian Reserve
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mr. Cooper Group Inc. (Nasdaq – COOP), Beacon Roofing Supply, Inc. (NasdaqBECN), Optinose, Inc. (NasdaqOPTN), Redfin Corporation (NasdaqRDFN - TradingView
Bank of New York Mellon Corp Sells 170,507 Shares of OptiNose, Inc. (NASDAQ:OPTN) - Defense World
Optinose Reports 2024 Financial Results, Highlights Prescription Growth and First Operational Income - MyChesCo
OptiNose (OPTN) Reports Q4 Loss, Tops Revenue Estimates - MSN
OptiNose earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Optinose Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Operational Highlights - GlobeNewswire
OptiNose: Q4 Earnings Snapshot - The Washington Post
OPTINOSE Earnings Results: $OPTN Reports Quarterly Earnings - Nasdaq
OptiNose Q4 Net Loss Narrows - Nasdaq
OptiNose Q4 Income From Operations USD 354 Thousand - MarketScreener
OptiNose Inc. Q4 Loss Decreases, Beats Estimates - Nasdaq
Philly weekly roundup: Proscia's $50M raise; Optinose acquired; A new biotech startup incubator - Technical.ly
Wall Street Analysts Believe OptiNose (OPTN) Could Rally 143.06%: Here's is How to Trade - Yahoo Finance
Paratek Pharmaceuticals’ Acquisition of Optinose - Global Legal Chronicle
Piper Sandler Reaffirms Neutral Rating for OptiNose (NASDAQ:OPTN) - Defense World
HC Wainwright Reaffirms Neutral Rating for OptiNose (NASDAQ:OPTN) - Defense World
OptiNose (NASDAQ:OPTN) Cut to “Hold” at Piper Sandler - Defense World
OptiNose (NASDAQ:OPTN) Rating Lowered to “Hold” at Lake Street Capital - Defense World
OPTINOSE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of OptiNose, Inc.OPTN - Business Wire
Earnings To Watch: OptiNose Inc (OPTN) Reports Q4 2024 Result - GuruFocus
OPTN Stock Soars 53% on Inking $330M Deal to be Acquired by Paratek - MSN
Paratek Pharmaceuticals Acquires Yardley-Based Optinose in $330M Deal - BUCKSCO.Today
This FedEx Analyst Turns Bearish; Here Are Top 5 Downgrades For Friday - Benzinga
Further Upside For OptiNose, Inc. (NASDAQ:OPTN) Shares Could Introduce Price Risks After 56% Bounce - Simply Wall St
Why OptiNose Inc. (OPTN) Surged On Thursday? - Insider Monkey
ProAssurance (PRA) and Optinose (OPTN) soar on M&A news - Investorsobserver
Darden Restaurants, Nike, Optinose - TradingView
Optinose Shares Soar After Merger Agreement With Paratek Pharmaceuticals: Retail Sentiment Takes Flight - Asianet Newsable
10 Micro-, Small-Cap Firms Dominate Thursday’s Gains - Insider Monkey
Lake Street cuts Optinose stock rating, lowers target to $9 By Investing.com - Investing.com Australia
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of OptiNose, Inc.OPTN - The Malaysian Reserve
Paratek To Acquire Optinose, Expanding Portfolio Beyond Antibiotics - insights.citeline.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, BECN, OPTN on Behalf of Shareholders - The Malaysian Reserve
Sector Update: Health Care Stocks Mixed in Afternoon Trading -March 20, 2025 at 02:03 pm EDT - Marketscreener.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Beacon Roofing Supply, Inc. (Nasdaq – BECN), Optinose, Inc. (Nasdaq – OPTN), Corporation (Nasdaq – RDFN), Blackboxstocks Inc. (Nasdaq – BLBX) - TradingView
Optinose to be acquired by Boston-based Paratek Pharmaceuticals in potential $330M deal - The Business Journals
Piper Sandler Downgrades OptiNose to Neutral From Overweight, $9 Price Target -March 20, 2025 at 12:32 pm EDT - Marketscreener.com
Paratek to buy Optinose for up to $330 million - The Pharma Letter
Optinose Inc (OPTN) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
0.80%
大文字化:
|
ボリューム (24 時間):